← Evidence map

ArticleBlood advances2026

Long-term follow-up of zevor-cel in patients with relapsed/refractory multiple myeloma.

Chengcheng Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41160798